104 related articles for article (PubMed ID: 2698437)
1. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
Pilheu JA; Galati MR; Yunis AS; De Salvo MC; Negroni R; García Fernández JC; Mingolla L; Rubio MC; Masana M; Acevedo C
Medicina (B Aires); 1989; 49(1):43-7. PubMed ID: 2698437
[TBL] [Abstract][Full Text] [Related]
2. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
[TBL] [Abstract][Full Text] [Related]
3. Interaction of ketoconazole with rifampin and isoniazid.
Engelhard D; Stutman HR; Marks MI
N Engl J Med; 1984 Dec; 311(26):1681-3. PubMed ID: 6095080
[No Abstract] [Full Text] [Related]
4. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
Zwolska Z; Niemirowska-Mikulska H; Augustynowicz-Kopec E; Walkiewicz R; Stambrowska H; Safianowska A; Grubek-Jaworska H
Int J Tuberc Lung Dis; 1998 Oct; 2(10):824-30. PubMed ID: 9783530
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of rifampicin and isoniazid in tuberculosis.
Seth V; Beotra A; Seth SD; Semwal OP; Kabra S; Jain Y; Mukhopadhya S
Indian Pediatr; 1993 Sep; 30(9):1091-8. PubMed ID: 8125594
[TBL] [Abstract][Full Text] [Related]
8. Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters.
Woo J; Chan C; Chan R; Cheung W; Or K; Chan K
J Med; 1995; 26(5-6):279-94. PubMed ID: 8721904
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
[TBL] [Abstract][Full Text] [Related]
10. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
Knop P; Kindler U; Austerhoff A
Dtsch Med Wochenschr; 1977 Dec; 102(52):1913-5. PubMed ID: 598300
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
Nouhouayi A; Bergogne-Berezin E; Lafaix C
Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
14. Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
McConkey B; Situnayake RD
J Rheumatol; 1988 Jan; 15(1):46-50. PubMed ID: 3351840
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
Panchagnula R; Singh I; Kaur KJ; Kaul CL
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):625-8. PubMed ID: 10669909
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
Zwolska Z; Augustynowicz-Kopeć E; Niemirowska-Mikulska H
Acta Pol Pharm; 2002; 59(6):448-52. PubMed ID: 12669769
[TBL] [Abstract][Full Text] [Related]
17. [Adjusting or not adjusting isoniazid dosage?].
Parrot R; Boval C; Grosset J; Gaillard JP
Rev Fr Mal Respir; 1983; 11(5):705-12. PubMed ID: 6658156
[TBL] [Abstract][Full Text] [Related]
18. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
Titarenko OT; Vakhmistrova TI; Perova TL
Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
[TBL] [Abstract][Full Text] [Related]
19. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
[No Abstract] [Full Text] [Related]
20. Isoniazid and acetylisoniazid kinetics in serum and urine in pulmonary primary complex with intermittent regimen.
Seth V; Seth SD; Beotra A; Semwal OP; D'monty V; Mukhopadhya S
Indian Pediatr; 1994 Mar; 31(3):279-85. PubMed ID: 7896362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
